HD-OPM Archive
Topics › Statins

Statin use linked to lower liver decompensation risk in primary biliary cholangitis

Louis Nervegna · Feb 20, 2026 · ♥ 7 reactions · 4 comments · original Facebook post
StatinsWeight, visceral & liver fat
AI summary & key facts

Medscape reports new research that statins were linked to lower hepatic decompensation and major adverse liver outcomes in PBC, adding to evidence of liver benefits. Louis links earlier posts.

This latest study adds to the growing evidence that statins protect the liver in the long term.

See these previous posts:

↪ Statins may benefit chronic liver disease rather than harm it, per a review

↪ Statin use linked to lower liver cancer and decompensation in chronic liver disease

↪ Ezetimibe-type absorption inhibitors linked to 31% lower liver cancer odds; statins 35%

↪ Statin-attributable abnormal liver tests occur in about 1 in 1,000 people

#statinsHD #liverHD #statinsliverHD

Research cited

Shared from Medscape · original post

New research suggests statin use in patients with primary biliary cholangitis was linked to a lower risk of hepatic decompensation and major adverse liver outcomes. The findings add to growing evidence that statins may offer benefits beyond cardiovascular risk reduction—but questions remain about optimal use and patient selection. Statin Use Tied to Lower Hepatic Decompensation Risk in PBC (Medscape)

No photo description available.
← newer: Why excess salt raises blood pressure (video)older: ARB blood pressure drugs such as losartan may lower cancer r →